Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors. Sorror, M. L., Storer, B., Sandmaier, B. M., Franke, G. N., Laport, G. G., Chauncey, T., Agura, E., Maris, M. T., Wade, J., Pulsipher, M. A., Maziarz, R. T., Sahebi, F., McSweeney, P., Bruno, B., Vindelov, L., Yeager, A. M., Rezvani, A., Niederwieser, D. W., Blume, K. G., Storb, R. F., Maloney, D. G. AMER SOC HEMATOLOGY. 2010: 553
View details for Web of Science ID 000289662201395